¹Department of Medical Genetics, University of Alberta and Cytogenetics Laboratory, Stollery Children's Hospital, Edmonton, AB, Canada

²Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada

³Department of Laboratory Medicine, The Credit Valley Hospital, Mississauga, ON, Canada

Correspondence to: D J Tomkins, Department of Medical Genetics, 825 Medical Sciences Building, University of Alberta, Edmonton, AB T6G 2H7, Canada. Tel: (780) 407 1542; Fax: (780) 407 3059; E-mail: d.tomkins@ualberta.ca

A 46,X,r(X) karyotype was found in a three and a half year old girl with short stature, facial dysmorphism and developmental delay. The clinical findings were consistent with the phenotype described in a limited number of patients with small ring X chromosomes lacking the XIST locus, a critical player in the process of X chromosome inactivation. Surprisingly, in our patient, fluorescent in situ hybridisation demonstrated that the XIST locus was present on the ring X. However, expression studies showed that there was no XIST transcript in peripheral blood cells, suggesting that the ring X had not been inactivated. This was confirmed by the demonstration that both of the patient's alleles for the androgen receptor gene were unmethylated, and that both of the patient's ZXDA alleles were expressed. The active nature of the ring X would presumably result in overexpression of genes that may account for the developmental delay observed for the patient. Using polymorphic markers along the X chromosome, the ring X was determined to be of paternal origin with one breakpoint in the long arm between DXS8037 and XIST and one in the short arm in Xp11.2 between DXS1126 and DXS991. To attempt to determine why the XIST gene failed to be expressed, the promoter region was sequenced and found to have a base change at the same location as a variant previously associated with nonrandom X chromosome inactivation. This mutation was not seen in over one hundred normal X chromosomes examined; however, it was observed in the paternal grandmother who did not show substantial skewing of X chromosome inactivation.

European Journal of Human Genetics (2002) 10, 44-51 DOI: 10.1038/sj/ejhg/5200757

ring X; XIST; X chromosome inactivation; dosage compensation; Turner syndrome